Autopsy report · NCT01849757

Comparison of Priming Constituents in Patients Undergoing CPB Assisted Cardiac Surgery: HES 130/0.4 or Albumin 5%

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Pentaspan is no longer used at our institution. Pentaspan was an arm of the study”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Na
Sponsor: University of Saskatchewan
Sponsor type: University, hospital or other
Conditions: Coronary Artery Disease; Aortic Valve Disease; Mitral Valve Disease
Interventions: prime crystalloid; Human Albumin; Voluven
Participants: 0
Sites: 1
Countries: Canada

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.